{
    "ticker": "COCH",
    "name": "Cochlear Limited",
    "description": "Cochlear Limited is a global leader in implantable hearing solutions, committed to improving the lives of individuals with hearing loss. Founded in 1981 and headquartered in Sydney, Australia, Cochlear designs, manufactures, and sells a range of innovative hearing devices, including cochlear implants, bone conduction implants, and acoustic implants. The company\u2019s flagship product, the cochlear implant, has transformed the lives of over 700,000 people worldwide, enabling them to experience sound and communicate effectively. Cochlear's advanced technology integrates sophisticated sound processing with user-friendly features, making hearing accessible for people of all ages. The company continues to invest heavily in research and development to enhance its product offerings, ensuring that patients receive the best possible hearing solutions. Cochlear also focuses on providing comprehensive support services to users and their families, including rehabilitation and educational resources. With a strong commitment to innovation, Cochlear aims to expand its global reach and further its mission of helping those with hearing loss to connect with the world around them.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Sydney, Australia",
    "founded": "1981",
    "website": "https://www.cochlear.com",
    "ceo": "Dig Howitt",
    "social_media": {
        "twitter": "https://twitter.com/Cochlear",
        "linkedin": "https://www.linkedin.com/company/cochlear-limited",
        "facebook": "https://www.facebook.com/Cochlear",
        "instagram": "https://www.instagram.com/cochlear/ "
    },
    "investor_relations": "https://investors.cochlear.com.au",
    "key_executives": [
        {
            "name": "Dig Howitt",
            "position": "CEO"
        },
        {
            "name": "Antonio Rodriguez",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Cochlear Implants",
            "products": [
                "Nucleus Implant",
                "Nucleus 7 Sound Processor"
            ]
        },
        {
            "category": "Bone Conduction Implants",
            "products": [
                "BAHA System",
                "BONEBRIDGE"
            ]
        }
    ],
    "seo": {
        "meta_title": "Cochlear Limited | Innovative Hearing Solutions",
        "meta_description": "Cochlear Limited is a global leader in implantable hearing solutions, dedicated to improving the lives of people with hearing loss through innovative technology and comprehensive support.",
        "keywords": [
            "Cochlear",
            "Hearing Solutions",
            "Cochlear Implants",
            "Healthcare",
            "Medical Devices",
            "Hearing Loss"
        ]
    },
    "faq": [
        {
            "question": "What products does Cochlear offer?",
            "answer": "Cochlear offers a range of products including cochlear implants, bone conduction implants, and acoustic implants."
        },
        {
            "question": "Who is the CEO of Cochlear?",
            "answer": "The CEO of Cochlear Limited is Dig Howitt."
        },
        {
            "question": "Where is Cochlear headquartered?",
            "answer": "Cochlear is headquartered in Sydney, Australia."
        },
        {
            "question": "When was Cochlear founded?",
            "answer": "Cochlear was founded in 1981."
        }
    ],
    "competitors": [
        "OTIC",
        "GN",
        "WSO",
        "ELOS"
    ],
    "related_stocks": [
        "MDT",
        "SYK",
        "ABT",
        "BSX"
    ]
}